Group One Trading
NAGE

Group One Trading’s Niagen Bioscience NAGE Stock Holding History

Group One Trading’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.3K Buy
17,755
+7,470
+73% +$40.3K ﹤0.01% 4936
2025
Q4 		$65.4K Buy
+10,285
New +$71.6K ﹤0.01% 5366
2025
Q2 		– Sell
-9,554
Closed -$94.3K – 8811
2025
Q1 		$65.9K Buy
+9,554
New +$60K ﹤0.01% 4936
2024
Q4 		– Sell
-7,283
Closed -$39.9K – 8099
2024
Q3 		$26.6K Buy
7,283
+4,900
+206% +$15.4K ﹤0.01% 5074
2024
Q2 		$6.51K Sell
2,383
-8,796
-79% -$29.4K ﹤0.01% 5840
2024
Q1 		$38.9K Buy
11,179
+4,500
+67% +$8.33K ﹤0.01% 4921
2023
Q4 		$9.55K Buy
6,679
+3,932
+143% +$5.48K ﹤0.01% 6235
2023
Q3 		$4.01K Sell
2,747
-10,000
-78% -$15.6K ﹤0.01% 6801
2023
Q2 		$20K Buy
+12,747
New +$19K ﹤0.01% 5997
2022
Q4 		– Sell
-34,458
Closed -$54.6K – 8246
2022
Q3 		$42K Sell
34,458
-4,000
-10% -$6.44K ﹤0.01% 5549
2022
Q2 		$64K Buy
38,458
+4,556
+13% +$8.91K ﹤0.01% 5363
2022
Q1 		$83K Buy
33,902
+14,578
+75% +$39.8K ﹤0.01% 5681
2021
Q4 		$72K Sell
19,324
-56,243
-74% -$304K ﹤0.01% 6032
2021
Q3 		$474K Sell
75,567
-171,948
-69% -$1.42M ﹤0.01% 4246
2021
Q2 		$2.44M Sell
247,515
-371,247
-60% -$3.24M ﹤0.01% 2428
2021
Q1 		$5.78M Buy
+618,762
New +$4.9M 0.01% 1388
2020
Q2 		– Sell
-27,542
Closed -$90K – 6277
2020
Q1 		$90K Hold
27,542
– – ﹤0.01% 3380
2019
Q4 		$119K Buy
+27,542
New +$97.9K ﹤0.01% 3527
2017
Q4 		– Sell
-4,000
Closed -$21.6K – 5305
2017
Q3 		$17K Buy
+4,000
New +$14.6K ﹤0.01% 4134
2016
Q4 		– Sell
-200
Closed -$1K – 4901
2016
Q3 		$1K Hold
200
– – ﹤0.01% 4458
2016
Q2 		$1K Buy
+200
New +$946 ﹤0.01% 4533

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's NAGE Position: Q1 2026 in Review

Group One Trading increased its Niagen Bioscience (NAGE) stake by 73% in Q1 2026, buying an estimated $40.3K and bringing the position to 17,755 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4936.

Group One Trading first reported a position in NAGE in Q2 2016 and has held it in 21 quarters since. The position peaked at $5.78M in Q1 2021. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Group One Trading held 17,755 shares of Niagen Bioscience worth $78.3K as of Q1 2026.
  • Group One Trading bought 7,470 Niagen Bioscience shares in Q1 2026, an estimated $40.3K.
  • Niagen Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4936 holding.
  • Group One Trading first reported a position in Niagen Bioscience in Q2 2016 and has held it in 21 quarters since.
  • Group One Trading's Niagen Bioscience position peaked at $5.78M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.